Literature DB >> 22868807

Association between ischemia-modified albumin, homocysteine, vitamin B(12) and folic acid in patients with severe sepsis.

Said Sami Erdem1, Fatma Hümeyra Yerlikaya, Hümeyra Çiçekler, Mehmet Gül.   

Abstract

BACKGROUND: The aim of the present study was to investigate serum ischemia-modified albumin (IMA), homocysteine, malondialdehyde (MDA), vitamin B(12) and folic acid levels in patients with severe sepsis, compared to healthy control subjects. Also, we examined associations of these parameters with high-sensitivity C-reactive protein (hsCRP) in patients with severe sepsis and healthy control subjects.
METHODS: This study was performed on 71 (40 male, 31 female) patients with severe sepsis aged 18-65 years and 70 (34 male, 36 female) healthy control subjects aged 18-65 years. Samples of patients were obtained at study entry within 24 h of onset of severe sepsis.
RESULTS: Serum IMA, homocysteine and MDA levels of the patients with severe sepsis were significantly higher than those of the healthy control subjects (p<0.01 for IMA and homocysteine, and p<0.001 for MDA). There was no significant difference between serum vitamin B(12) and folic acid levels of the groups. Serum hsCRP levels were positively correlated with IMA (p<0.01) and MDA (p<0.01) in the patients with severe sepsis.
CONCLUSIONS: Our findings show that IMA may be useful as a prognostic biomarker because it can indicate the severity of illness in patients with sepsis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22868807     DOI: 10.1515/cclm-2011-0794

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  2 in total

1.  [Metabolomic changes of neonatal sepsis: an exploratory clinical study].

Authors:  Ping Tong; Fu-Rong Huang; Jun Xu; Zi-Qi Wu; Xing Hu; Ming Ling; Die Wang; Bu-Fei Wu; Du-Jiao Yang; Ai-Min Zhang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-06-15

2.  Sustained high serum malondialdehyde levels are associated with severity and mortality in septic patients.

Authors:  Leonardo Lorente; María M Martín; Pedro Abreu-González; Alberto Domínguez-Rodriguez; Lorenzo Labarta; César Díaz; Jordi Solé-Violán; José Ferreres; Judith Cabrera; Jose Carlos Igeño; Alejandro Jiménez
Journal:  Crit Care       Date:  2013-12-11       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.